» Articles » PMID: 27521008

Sonic Hedgehog Protein : A Novel Approach to the Treatment of Neurodegenerative Disorders?

Overview
Journal CNS Drugs
Specialties Neurology
Pharmacology
Date 2016 Aug 14
PMID 27521008
Authors
Affiliations
Soon will be listed here.
Abstract

Sonic hedgehog is a member of a newly discovered family of molecules that are active during development in vertebrates. Sonic hedgehog induces development of key CNS neuronal cell types, including the dopaminergic neurons that are destroyed in Parkinson's disease. In addition to developmental-inducing activity, Sonic hedgehog has neurotrophic and neuroprotective activities on many of these same cell types. These activities suggest interesting clinical potentials for Sonic hedgehog in neurodegenerative diseases such as Parkinson's disease and in acute CNS trauma such as stroke.

References
1.
Quinn N . Drug treatment of Parkinson's disease. BMJ. 1995; 310(6979):575-9. PMC: 2548944. DOI: 10.1136/bmj.310.6979.575. View

2.
Eriksson N, Lindsay R, Aldskogius H . BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. Neuroreport. 1994; 5(12):1445-8. View

3.
Casper D, Mytilineou C, Blum M . EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J Neurosci Res. 1991; 30(2):372-81. DOI: 10.1002/jnr.490300213. View

4.
Tanabe Y, Roelink H, Jessell T . Induction of motor neurons by Sonic hedgehog is independent of floor plate differentiation. Curr Biol. 1995; 5(6):651-8. DOI: 10.1016/s0960-9822(95)00130-8. View

5.
Gao W, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M . Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol. 1995; 38(1):30-7. DOI: 10.1002/ana.410380108. View